Published in Hepatol Res on May 31, 2016
Therapeutic evaluation of arterio-portal fistula-related gastroesophageal variceal bleeding. Oncotarget (2017) 0.75
A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet. Liver Int (2011) 1.65
Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy (2013) 1.19
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study. Hepatol Res (2008) 0.91
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Hepatology (2015) 0.83
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. J Gastroenterol (2015) 0.81
Biphasic effect of alcohol intake on the development of fatty liver disease. J Gastroenterol (2015) 0.79
Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis. Hepatol Res (2014) 0.75
Are genetic variations the most important risk factors for development of hepatocellular carcinoma? J Gastroenterol (2015) 0.75
Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res (2017) 0.75
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy. Sci Rep (2022) 0.75
Simultaneous occurrence of gastric lipoma and early gastric cancer. Endoscopy (2014) 0.75
First successful case of simultaneous liver and kidney transplantation for patients with chronic liver and renal failure in Japan. Hepatol Res (2013) 0.75
Spur cells and acanthocytes in liver diseases. Hepatol Res (2007) 0.75